{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:52:19Z","timestamp":1784829139790,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s43440-019-00002-3","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T13:02:52Z","timestamp":1578488572000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The inhibitory effect of Ph\u03b11\u03b2 toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor"],"prefix":"10.1007","volume":"72","author":[{"given":"Claudio Antonio","family":"da Silva Junior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lio Jos\u00e9","family":"de Castro Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizete Maria Rita","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Scardua","family":"Binda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Figueira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"do Nascimento Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuza Montijo","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Santa","family":"Cecilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliano","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vinicius","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,8]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","volume":"152","author":"TS Jensen","year":"2011","unstructured":"Jensen TS, Baron R, Haanpaa M, Kalso E, Loeser JD, Rice ASC, et al. A new definition of neuropathic pain. Pain. 2011;152:2204\u20135. https:\/\/doi.org\/10.1016\/j.pain.2011.06.017.","journal-title":"Pain"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","volume":"166","author":"AJF King","year":"2012","unstructured":"King AJF. The use of animal models in diabetes research. Br J Pharmacol. 2012;166:877\u201394. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01911.x.","journal-title":"Br J Pharmacol"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0140-6736(11)60679-x","volume":"378","author":"G Danaei","year":"2011","unstructured":"Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet (London, England). 2011;378:31\u201340. https:\/\/doi.org\/10.1016\/s0140-6736(11)60679-x.","journal-title":"Lancet (London, England)"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/AJP.0b013e318243075c","volume":"28","author":"V Spallone","year":"2012","unstructured":"Spallone V, Lacerenza M, Rossi A, Sicuteri R, Marchettini P. Painful diabetic polyneuropathy: approach to diagnosis and management. Clin J Pain. 2012;28:726\u201343. https:\/\/doi.org\/10.1097\/AJP.0b013e318243075c.","journal-title":"Clin J Pain"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.pain.2010.12.014","volume":"152","author":"A Boroujerdi","year":"2011","unstructured":"Boroujerdi A, Zeng J, Sharp K, Kim D, Steward O, Luo ZD. Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states. Pain. 2011;152:649\u201355. https:\/\/doi.org\/10.1016\/j.pain.2010.12.014.","journal-title":"Pain"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00210-015-1145-y","volume":"388","author":"G Ali","year":"2015","unstructured":"Ali G, Subhan F, Abbas M, Zeb J, Shahid M, Sewell RDE. A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentin. Naunyn Schmiedebergs Arch Pharmacol. 2015;388:1129\u201340. https:\/\/doi.org\/10.1007\/s00210-015-1145-y.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/35093019","volume":"413","author":"D Julius","year":"2001","unstructured":"Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature. 2001;413:203\u201310. https:\/\/doi.org\/10.1038\/35093019.","journal-title":"Nature"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S1359-6446(05)03662-7","volume":"11","author":"JG McGivern","year":"2006","unstructured":"McGivern JG. Targeting N-type and T-type calcium channels for the treatment of pain. Drug Discov Today. 2006;11:245\u201353. https:\/\/doi.org\/10.1016\/S1359-6446(05)03662-7.","journal-title":"Drug Discov Today"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2147\/TCRM.S4438","volume":"5","author":"HS Smith","year":"2009","unstructured":"Smith HS, Deer TR. Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain. Ther Clin Risk Manag. 2009;5:521\u201334.","journal-title":"Ther Clin Risk Manag"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0304-3959(99)00254-7","volume":"85","author":"RD Penn","year":"2000","unstructured":"Penn RD, Paice JA. Adverse effects associated with the intrathecal administration of ziconotide. Pain. 2000;85:291\u20136.","journal-title":"Pain"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.291.1.63","volume":"291","author":"PS Staats","year":"2004","unstructured":"Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA. 2004;291:63\u201370. https:\/\/doi.org\/10.1001\/jama.291.1.63.","journal-title":"JAMA"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1124\/jpet.105.087023","volume":"314","author":"LB Vieira","year":"2005","unstructured":"Vieira LB, Kushmerick C, Hildebrand ME, Garcia E, Stea A, Cordeiro MN, et al. Inhibition of high voltage-activated calcium channels by spider toxin PnTx3-6. J Pharmacol Exp Ther. 2005;314:1370\u20137. https:\/\/doi.org\/10.1124\/jpet.105.087023.","journal-title":"J Pharmacol Exp Ther"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.pain.2008.07.014","volume":"140","author":"AH Souza","year":"2008","unstructured":"Souza AH, Ferreira J, do Cordeiro MN, Vieira LB, De Castro CJ, Trevisan G, et al. Analgesic effect in rodents of native and recombinant Ph\u03b11\u03b2 toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venom. Pain. 2008;140:115\u201326. https:\/\/doi.org\/10.1016\/j.pain.2008.07.014.","journal-title":"Pain"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10571-012-9871-x","volume":"33","author":"AH de Souza","year":"2013","unstructured":"de Souza AH, Castro CJJ, Rigo FK, de Oliveira SM, Gomez RS, Diniz DM, et al. An evaluation of the antinociceptive effects of Ph\u03b11\u03b2, a neurotoxin from the spider Phoneutria nigriventer, and omega-conotoxin MVIIA, a cone snail Conus magus toxin, in rat model of inflammatory and neuropathic pain. Cell Mol Neurobiol. 2013;33:59\u201367. https:\/\/doi.org\/10.1007\/s10571-012-9871-x.","journal-title":"Cell Mol Neurobiol"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1213\/ane.0000000000000249","volume":"119","author":"F Rosa","year":"2014","unstructured":"Rosa F, Trevisan G, Rigo FK, Tonello R, Andrade EL, do Cordeiro MN, et al. Ph\u03b11\u03b2, a peptide from the venom of the spider Phoneutria nigriventer shows antinociceptive effects after continuous infusion in a neuropathic pain model in rats. Anesth Analg. 2014;119:196\u2013202. https:\/\/doi.org\/10.1213\/ane.0000000000000249.","journal-title":"Anesth Analg"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1097\/j.pain.0000000000001061","volume":"158","author":"E Backryd","year":"2017","unstructured":"Backryd E, Lind A-L, Thulin M, Larsson A, Gerdle B, Gordh T. High levels of cerebrospinal fluid chemokines point to the presence of neuroinflammation in peripheral neuropathic pain: a cross-sectional study of 2 cohorts of patients compared with healthy controls. Pain. 2017;158:2487\u201395. https:\/\/doi.org\/10.1097\/j.pain.0000000000001061.","journal-title":"Pain"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"20151","DOI":"10.1073\/pnas.0709250104","volume":"104","author":"FA White","year":"2007","unstructured":"White FA, Jung H, Miller RJ. Chemokines and the pathophysiology of neuropathic pain. Proc Natl Acad Sci USA. 2007;104:20151\u20138. https:\/\/doi.org\/10.1073\/pnas.0709250104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1744-8069-5-48","volume":"5","author":"SK Bhangoo","year":"2009","unstructured":"Bhangoo SK, Ripsch MS, Buchanan DJ, Miller RJ, White FA. Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Mol Pain. 2009;5:48. https:\/\/doi.org\/10.1186\/1744-8069-5-48.","journal-title":"Mol Pain"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.bbi.2006.12.003","volume":"21","author":"SK Bhangoo","year":"2007","unstructured":"Bhangoo SK, Ren D, Miller RJ, Chan DM, Ripsch MS, Weiss C, et al. CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy. Brain Behav Immun. 2007;21:581\u201391. https:\/\/doi.org\/10.1016\/j.bbi.2006.12.003.","journal-title":"Brain Behav Immun"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1744-8069-10-42","volume":"10","author":"DM Menichella","year":"2014","unstructured":"Menichella DM, Abdelhak B, Ren D, Shum A, Frietag C, Miller RJ. CXCR4 chemokine receptor signaling mediates pain in diabetic neuropathy. Mol Pain. 2014;10:42. https:\/\/doi.org\/10.1186\/1744-8069-10-42.","journal-title":"Mol Pain"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0041-0101(93)90354-L","volume":"31","author":"MN do Cordeiro","year":"1993","unstructured":"do Cordeiro MN, de Figueiredo SG, do Valentim AC, Diniz CR, von Eickstedt VR, Gilroy J, et al. Purification and amino acid sequences of six Tx3 type neurotoxins from the venom of the Brazilian \u201carmed\u201d spider Phoneutria nigriventer (Keys). Toxicon. 1993;31:35\u201342.","journal-title":"Toxicon"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0301-0082(98)00048-3","volume":"57","author":"MJ Millan","year":"1999","unstructured":"Millan MJ. The induction of pain: an integrative review. Prog Neurobiol. 1999;57:1\u2013164.","journal-title":"Prog Neurobiol"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5681\/bi.2011.016","volume":"1","author":"T Ghaffari","year":"2011","unstructured":"Ghaffari T, Nouri M, Irannejad E, Rashidi M-R. Effect of vitamin e and selenium supplement on paraoxonase-1 activity, oxidized low density lipoprotein and antioxidant defense in diabetic rats. Bioimpacts. 2011;1:121\u20138. https:\/\/doi.org\/10.5681\/bi.2011.016.","journal-title":"Bioimpacts"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"487816","DOI":"10.1155\/2015\/487816","volume":"2015","author":"RG Peterson","year":"2015","unstructured":"Peterson RG, Jackson CV, Zimmerman K, de Winter W, Huebert N, Hansen MK. Characterization of the ZDSD rat: a translational model for the study of metabolic syndrome and type 2 diabetes. J Diabetes Res. 2015;2015:487816. https:\/\/doi.org\/10.1155\/2015\/487816.","journal-title":"J Diabetes Res"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","volume":"67","author":"JL Hylden","year":"1980","unstructured":"Hylden JL, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur J Pharmacol. 1980;67:313\u20136.","journal-title":"Eur J Pharmacol"},{"key":"2_CR26","first-page":"939","volume":"299","author":"X Li","year":"2001","unstructured":"Li X, Eisenach JC. alpha2A-adrenoceptor stimulation reduces capsaicin-induced glutamate release from spinal cord synaptosomes. J Pharmacol Exp Ther. 2001;299:939\u201344.","journal-title":"J Pharmacol Exp Ther"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248\u201354.","journal-title":"Anal Biochem"},{"key":"2_CR28","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","volume":"260","author":"G Grynkiewicz","year":"1985","unstructured":"Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440\u201350.","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"2_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/bj2960313","volume":"296","author":"MA Romano-Silva","year":"1993","unstructured":"Romano-Silva MA, Ribeiro-Santos R, Ribeiro AM, Gomez MV, Diniz CR, Cordeiro MN, et al. Rat cortical synaptosomes have more than one mechanism for Ca2+ entry linked to rapid glutamate release: studies using the Phoneutria nigriventer toxin PhTX2 and potassium depolarization. Biochem J. 1993;296(Pt 2):313\u20139. https:\/\/doi.org\/10.1042\/bj2960313.","journal-title":"Biochem J"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.2337\/db06-1176","volume":"56","author":"IG Obrosova","year":"2007","unstructured":"Obrosova IG, Ilnytska O, Lyzogubov VV, Pavlov IA, Mashtalir N, Nadler JL, et al. High-fat diet induced neuropathy of pre-diabetes and obesity: effects of \u201chealthy\u201d diet and aldose reductase inhibition. Diabetes. 2007;56:2598\u2013608. https:\/\/doi.org\/10.2337\/db06-1176.","journal-title":"Diabetes"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"15185","DOI":"10.1074\/jbc.M115.644476","volume":"290","author":"DA Andersson","year":"2015","unstructured":"Andersson DA, Filipovic MR, Gentry C, Eberhardt M, Vastani N, Leffler A, et al. Streptozotocin stimulates the ion channel TRPA1 directly: involvement of peroxynitrite. J Biol Chem. 2015;290:15185\u201396. https:\/\/doi.org\/10.1074\/jbc.M115.644476.","journal-title":"J Biol Chem"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/35036035","volume":"1","author":"MJ Berridge","year":"2000","unstructured":"Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1:11\u201321. https:\/\/doi.org\/10.1038\/35036035.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.2174\/138161211798764825","volume":"17","author":"A-M Kampoli","year":"2011","unstructured":"Kampoli A-M, Tousoulis D, Briasoulis A, Latsios G, Papageorgiou N, Stefanadis C. Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus. Curr Pharm Des. 2011;17:4147\u201358.","journal-title":"Curr Pharm Des"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/bph.12966","volume":"172","author":"RBM Silva","year":"2015","unstructured":"Silva RBM, Sperotto NDM, Andrade EL, Pereira TCB, Leite CE, de Souza AH, et al. Spinal blockage of P\/Q- or N-type voltage-gated calcium channels modulates functional and symptomatic changes related to haemorrhagic cystitis in mice. Br J Pharmacol. 2015;172:924\u201339. https:\/\/doi.org\/10.1111\/bph.12966.","journal-title":"Br J Pharmacol"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1515\/revneuro-2015-0016","volume":"27","author":"X Luo","year":"2016","unstructured":"Luo X, Wang X, Xia Z, Chung SK, Cheung CW. CXCL12\/CXCR4 axis: an emerging neuromodulator in pathological pain. Rev Neurosci. 2016;27:83\u201392. https:\/\/doi.org\/10.1515\/revneuro-2015-0016.","journal-title":"Rev Neurosci"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1523\/JNEUROSCI.21-14-05027.2001","volume":"21","author":"SB Oh","year":"2001","unstructured":"Oh SB, Tran PB, Gillard SE, Hurley RW, Hammond DL, Miller RJ. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci. 2001;21:5027\u201335.","journal-title":"J Neurosci"},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1111\/j.1460-9568.2012.08179.x","volume":"36","author":"A Reaux-Le Goazigo","year":"2012","unstructured":"Reaux-Le Goazigo A, Rivat C, Kitabgi P, Pohl M, Melik Parsadaniantz S. Cellular and subcellular localization of CXCL12 and CXCR4 in rat nociceptive structures: physiological relevance. Eur J Neurosci. 2012;36:2619\u201331. https:\/\/doi.org\/10.1111\/j.1460-9568.2012.08179.x.","journal-title":"Eur J Neurosci"},{"key":"2_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/bph.13652","volume":"174","author":"R Tonello","year":"2017","unstructured":"Tonello R, Fusi C, Materazzi S, Marone IM, De Logu F, Benemei S, et al. The peptide Ph\u03b11\u03b2, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice. Br J Pharmacol. 2017;174:57\u201369. https:\/\/doi.org\/10.1111\/bph.13652.","journal-title":"Br J Pharmacol"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/ALN.0b013e3181a1642b","volume":"111","author":"H Wei","year":"2009","unstructured":"Wei H, Hamalainen MM, Saarnilehto M, Koivisto A, Pertovaara A. Attenuation of mechanical hypersensitivity by an antagonist of the TRPA1 ion channel in diabetic animals. Anesthesiology. 2009;111:147\u201354. https:\/\/doi.org\/10.1097\/ALN.0b013e3181a1642b.","journal-title":"Anesthesiology"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.phrs.2011.10.006","volume":"65","author":"A Koivisto","year":"2012","unstructured":"Koivisto A, Hukkanen M, Saarnilehto M, Chapman H, Kuokkanen K, Wei H, et al. Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy. Pharmacol Res. 2012;65:149\u201358. https:\/\/doi.org\/10.1016\/j.phrs.2011.10.006.","journal-title":"Pharmacol Res"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-019-00002-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s43440-019-00002-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-019-00002-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T21:28:37Z","timestamp":1613424517000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s43440-019-00002-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,8]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1007\/s43440-019-00002-3","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,8]]},"assertion":[{"value":"5 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there are no conflicts of interest to disclose regarding this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}